Delivery Order SPE2DB22D2007-SPE2DB25FJ2PE
Award Date
6/26/25
Potential Completion Date
6/27/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,038.42, is for the delivery of 4568013716 - MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $2,064.26 and is a firm fixed-price type contract. The period of performance extends to May 27, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. The company holds a...
This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET UD 100S. The delivery order, valued at $4,908.94, is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,208.03 firm fixed-price contract is for the supply of MOVANTIK 12.5 MG TABLET 30S, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,531.81. The contract is a firm fixed price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Movantik 25 mg Tablet 30s, with a ceiling value of $4,048.26 and a period of performance through April 29, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,378.11, is for the delivery of Movantik 25 mg tablets. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price contract. This contract is not designated as a set-aside. AmerisourceBergen Drug Corporation holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Movantik 25 mg tablets, a prescription medication, with a ceiling value of $1,964.48 and a period of performance through April 2025. The contract is not set aside and was awarded as an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
The Defense Logistics Agency awarded a $3,514.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the 25 mg Movantik medication. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 14, 2023 to support DLA's medical supply needs. No subcontractors or set aside...